Analyst Ratings for Actinium Pharma (ATNM)
ATNM Rating Summary
ATNM Price Target Summary
- Highest: $4.00 (H.C. Wainwright)
- Lowest: $4.00 (H.C. Wainwright)
- Average: $4.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$4.00 (+233.3%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 85%
Rating Score: 8.2 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/7/2024 | B.Riley | Yuan Zhi | Downgrade | Neutral (Buy) |
2.00 (N/A) |
2.87 (1.20) |
-58.19% | Details |
| 5/14/2024 | Stephens » Updated 11/19/2024 |
Sudan Loganathan | New Coverage | Overweight (N/A) |
5.00 (N/A) |
8.73 (1.20) |
-86.25% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
